下一代三倍体形成的PNAs用于F508del CFTR突变的特定位点基因组编辑
Anisha Gupta1, Christina Barone2, Elias Quijano3
1Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06520, USA.
概括
通过纳米颗粒传递的化学修饰核酸 (PNA) 显示出通过增强CFTR基因编辑和功能来纠正囊性纤维化 (CF) 中的F508del突变的前景.
科学领域:
- 基因工程是一种基因工程.
- 纳米医学是一种纳米医学.
- 分子生物学分子生物学
背景情况:
- 囊性纤维化 (CF) 是一种致命的遗传疾病,由CFTR基因突变引起.
- 目前的治疗方法可以控制症状;治愈需要纠正潜在的遗传缺陷.
- 通过纳米粒子 (NP) 传递的核酸 (PNA) 已经显示出对CFTR基因突变纠正的潜力.
研究的目的:
- 为了评估下一代玛PNAs (γPNAs) 进行增强的CFTR基因校正.
- 评估gpnas在人类支气管和小鼠鼻上皮细胞中的疗效.
- 为了提高基因编辑效率,超出以前实现的治疗潜力的水平.
主要方法:
- 利用化学修饰的γPNA与乙烯糖醇替代物进行改进的DNA结合.
- 将加载的 γPNA 和捐赠者DNA 转化为可生物降解的纳米粒子 (NP).
- 在空气-液体界面 (ALI) 处理的人类支气管上皮细胞 (CFBE) 和初级CF小鼠鼻上皮细胞 (NECF).
主要成果:
- 在CFBE和NECF细胞中观察到F508del突变的增强基因校正.
- 治疗导致CFTR功能增加,通过短路电流测量.
- 基因组DNA分析显示,基因编辑效率有所提高,高达32%.
结论:
- 由NP传递的修改后γPNA显著增强CFTR基因校正.
- 这种PNA和NP技术对开发CF的基因疗法充满希望.
- 该平台的进一步开发可能会导致治疗囊性纤维化.
相关概念视频
Conservative Site-specific Recombination and Phase Variation
6.0K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.0K
CRISPR
50.1K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.1K


